Australia
· Delayed Price · Currency is AUD Cogstate Company Description
Cogstate Limited, a neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide.
It offers digital cognitive assessment, endpoint data quality (rater services), remote assessment, scientific consulting, healthcare cognitive screening, and research and academic collaboration solutions for various therapeutic areas, including Alzheimer’s disease and dementia, preclinical Alzheimer’s disease, pediatrics and rare disease, Parkinson’s disease, multiple sclerosis, schizophrenia, oncology, safety, and sleep and mood disorders.
The company also designs and provides quality assurance services in clinical trials focused on the administration, scoring, and recording of conventional brain health assessments.
In addition, it develops a tool for primary care physicians and/or hospitals to assess cognitive decline.
Its technology and associated services are used to quantify the effect of disease and drugs, devices, or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies.
The company serves biopharmaceutical companies, academic institutions, physicians, and patients. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.
| Country | Australia |
| Founded | 1999 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 160 |
| CEO | Bradley O'Connor |
Contact Details
Address: 367 Collins Street Melbourne, 3000 Australia | |
| Phone | 61 3 9664 1300 |
| Website | cogstate.com |
Stock Details
| Ticker Symbol | CGS |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| ISIN Number | AU000000CGS8 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Bradley John O'Connor B.Bus, C.A., CA | Chief Executive Officer, MD and Executive Director |
| Darren Watson | Chief Financial Officer |
| Dr. Pamela Ventola Ph.D. | Chief Science Officer |
| Rachel Colite | Executive Vice President of Clinical Trials |
| Prof. Paul Maruff BBSc (Hons), Ph.D. | Founder and Chief Innovation Officer |
| Kristi Geddes L.L.B. | General Counsel, Joint Company Secretary and Director |
| Kenneth Billard | Chief Commercial Officer |
| Dr. Kaycee Sink M.D. | Chief Medical Officer |
| David James Franks BEc, C.A., F Fin, J.P. | Joint Company Secretary |